9818 results
-
List item
Summary of opinion: Icatibant Accord
opinion date: 20/05/2021, Positive, Last updated: 20/05/2021Icatibant Accord: Pending EC decision … medicines are manufactured according to the same quality standards … authorisation) Icatibant Accord icatibant On 20 May 2020 … -
List item
Withdrawn application: Erlotinib Accord
erlotinib, date of withdrawal: 28/05/2020, Initial authorisation, Last updated: 29/05/2020Erlotinib Accord: Withdrawn application … medicines are manufactured according to the same quality standards … Erlotinib Accord Erlotinib Accord erlotinib … -
List item
Withdrawn application: Tigecycline Accord
tigecycline, date of withdrawal: 12/09/2017, Initial authorisation, Last updated: 10/10/2017Tigecycline Accord: Withdrawn application … application for Tigecycline Accord (tigecycline) On 12 September … On 12 September 2017, Accord Healthcare Limited officially … -
List item
Direct healthcare professional communication (DHPC): Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion
Active substance: cabazitaxel, DHPC type: Medication error, Last updated: 28/10/2020Cabazitaxel Accord 20 mg/mL concentrate for … Cabazitaxel Accord 20 mg/mL concentrate for … Cabazitaxel Accord Cabazitaxel Accord cabazitaxel cabazitaxel ca … -
List item
Human medicine European public assessment report (EPAR): Apixaban Accord (updated)
Apixaban, Venous Thromboembolism, Stroke, Arthroplasty
Date of authorisation: 23/07/2020,
, Revision: 1, Authorised, Last updated: 21/07/2021
Apixaban Accord Venous Thromboembolism Stro … apixaban Overview Apixaban Accord is a medicine used to prevent … reoccurrence. Additionally, Apixaban Accord is used to prevent stroke … -
List item
Human medicine European public assessment report (EPAR): Deferasirox Accord (updated)
deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 09/01/2020,, Revision: 1, Authorised, Last updated: 08/07/2021
Deferasirox Accord Iron Overload beta-Thalasse … deferasirox Overview Deferasirox Accord is a medicine used to treat … from the gut. Deferasirox Accord contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 7, Authorised, Last updated: 02/06/2021
Lenalidomide Accord Multiple Myeloma … lenalidomide Overview Lenalidomide Accord is a medicine used for the … multiple myeloma, Lenalidomide Accord is used: in adults who have … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,
, , Revision: 14, Authorised, Last updated: 04/06/2021
Capecitabine Accord Colonic Neoplasms Breast … capecitabine Overview Capecitabine Accord is a cancer medicine that … bowel) cancer. Capecitabine Accord is used on its own or with … -
List item
Human medicine European public assessment report (EPAR): Posaconazole Accord
posaconazole, Mycoses
Date of authorisation: 25/07/2019,, Revision: 2, Authorised, Last updated: 26/04/2021
Posaconazole Accord Mycoses … posaconazole Overview Posaconazole Accord is an antifungal medicine … in spores). Posaconazole Accord is also used to prevent invasive … -
List item
Human medicine European public assessment report (EPAR): Azacitidine Accord
azacitidine, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 14/04/2021
Azacitidine Accord Myelodysplastic Syndromes Leukemia … azacitidine Overview Azacitidine Accord is used for the treatment … myeloid cells). Azacitidine Accord is used in patients with … -
List item
Human medicine European public assessment report (EPAR): Bortezomib Accord
bortezomib, Multiple Myeloma
Date of authorisation: 20/07/2015,, Revision: 9, Authorised, Last updated: 24/03/2021
Bortezomib Accord Multiple Myeloma … bortezomib Overview Bortezomib Accord is a cancer medicine used … these patients, Bortezomib Accord is used either on its own … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Accord
temozolomide, Glioma, Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 20, Authorised, Last updated: 09/03/2021
Temozolomide Accord Glioma Glioblastoma … Report (EPAR) for Temozolomide Accord. It explains how the Committee … conditions of use for Temozolomide Accord. What is Temozolomide Accord? Temozolomide Accord is a cancer medicine that … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Accord
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 28/08/2015,, Revision: 9, Authorised, Last updated: 24/02/2021
Pregabalin Accord Anxiety Disorders Epilepsy … report (EPAR) for Pregabalin Accord. It explains how the Agency … on how to use Pregabalin Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord
Palonosetron, Vomiting, Nausea, Cancer
Date of authorisation: 26/05/2016,, Revision: 4, Authorised, Last updated: 18/02/2021
Palonosetron Accord Vomiting Nausea Cancer … report (EPAR) for Palonosetron Accord. It explains how the Agency … on how to use Palonosetron Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Accord
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 12, Authorised, Last updated: 10/02/2021
Levetiracetam Accord Epilepsy … EPAR) for Levetiracetam Accord. It explains how the Committee … of use for Levetiracetam Accord. What is Levetiracetam Accord? Levetiracetam Accord is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Entecavir Accord
Entecavir, Hepatitis B, Chronic
Date of authorisation: 25/09/2017,, Revision: 3, Authorised, Last updated: 29/01/2021
Entecavir Accord Hepatitis B, Chronic … report (EPAR) for Entecavir Accord. It explains how the Agency … advice on how to use Entecavir Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Eptifibatide Accord
eptifibatide, Myocardial Infarction
Date of authorisation: 11/01/2016,, Revision: 3, Authorised, Last updated: 21/10/2020
Eptifibatide Accord Myocardial Infarction … report (EPAR) for Eptifibatide Accord. It explains how the Agency … on how to use Eptifibatide Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 11, Authorised, Last updated: 21/10/2020
Aripiprazole Accord Schizophrenia Bipolar Disor … report (EPAR) for Aripiprazole Accord. It explains how the Agency … on how to use Aripiprazole Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Repaglinide Accord
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 22/12/2011,, Revision: 6, Authorised, Last updated: 30/09/2020
Repaglinide Accord Diabetes Mellitus, Type 2 … report (EPAR) for Repaglinide Accord. It explains how the Committee … conditions of use for Repaglinide Accord. What is Repaglinide Accord? Repaglinide Accord is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Accord
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Breast Neoplasms
Date of authorisation: 22/05/2012,, Revision: 14, Authorised, Last updated: 28/10/2020
Docetaxel Accord Head and Neck Neoplasms Carcinoma … docetaxel Overview Docetaxel Accord is a cancer medicine used … breast cancer. Docetaxel Accord can be used on its own after … -
List item
Human medicine European public assessment report (EPAR): Lacosamide Accord
lacosamide, Epilepsy
Date of authorisation: 18/09/2017,, Revision: 5, Authorised, Last updated: 22/07/2020
Lacosamide Accord Epilepsy … report (EPAR) for Lacosamide Accord. It explains how the Agency … on how to use Lacosamide Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Dexmedetomidine Accord
dexmedetomidine, Premedication
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 21/07/2020
Dexmedetomidine Accord Premedication … Overview Dexmedetomidine Accord is a medicine used to sedate … sedation). Dexmedetomidine Accord contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Voriconazole Accord
voriconazole, Aspergillosis, Candidiasis, Mycoses
Date of authorisation: 16/05/2013,, Revision: 12, Authorised, Last updated: 22/07/2020
Voriconazole Accord Aspergillosis Candidiasis … report (EPAR) for Voriconazole Accord. It explains how the Agency … on how to use Voriconazole Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Imatinib Accord
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 30/06/2013,, Revision: 16, Authorised, Last updated: 11/09/2020
Imatinib Accord Precursor Cell Lymphoblastic … report (EPAR) for Imatinib Accord. It explains how the Agency … advice on how to use Imatinib Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Fampridine Accord
Fampridine, Multiple Sclerosis
Date of authorisation: 24/09/2020,, Authorised, Last updated: 02/10/2020
Fampridine Accord Multiple Sclerosis … fampridine Overview Fampridine Accord is a medicine used to improve … and spinal cord. Fampridine Accord is a ‘generic medicine’ …